KP Tissue Inc. (TSE:KPT - Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$8.45 and traded as high as C$8.50. KP Tissue shares last traded at C$8.48, with a volume of 55,519 shares trading hands.
Wall Street Analyst Weigh In
Separately, TD Securities raised their price target on KP Tissue from C$8.50 to C$9.00 and gave the company a "hold" rating in a report on Wednesday, August 14th.
Get Our Latest Stock Analysis on KP Tissue
KP Tissue Price Performance
The stock's 50-day simple moving average is C$8.47 and its two-hundred day simple moving average is C$8.45. The firm has a market cap of C$84.35 million, a P/E ratio of 14.10, a PEG ratio of -0.88 and a beta of 0.37.
KP Tissue (TSE:KPT - Get Free Report) last announced its quarterly earnings data on Tuesday, August 13th. The company reported C$0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.22 by C($0.10). The business had revenue of C$509.80 million for the quarter, compared to analyst estimates of C$487.50 million. As a group, sell-side analysts expect that KP Tissue Inc. will post 0.442939 earnings per share for the current year.
KP Tissue Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, October 15th will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 8.51%. The ex-dividend date is Friday, September 27th. KP Tissue's dividend payout ratio (DPR) is presently 120.00%.
About KP Tissue
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Featured Articles
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
